Investors

Investors > FY 2023-24

Investors > FY 2023-24



1. Intimation to Stock Exchange

Intimation of Credit Rating
Transcript of Conference call with Analysts / Investors on Financial Results for Q2 2023-24
Compliance as per Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation for Presentation to analysts on financial Results for the quarter ended 30th September, 2023
Intimation for Concall with Investors/Analyst Q2_2023-24
Shareholding Pattern Q2
Intimation of the board meeting dated 23-10-2023
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Change in Senior Management Personnel (SMP)
Intimation for Trading Window Closure_Q2
Intimation of Credit Rating
Press Release – Torrent Pharmaceuticals gets EIR from US FDA for Dahej facility
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Transcript of Conference call with Analysts / Investors on Financial Results for the quarter ended 30th June, 2023
Newspaper Advertisement Results Q1
Voting Results & Scrutinizer’s Report AGM dated 07-08-2023
Appointment of Nikhil Khattau as an Independent Director of the Company
Alteration of Articles of Association of the Company
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Proceedings of 50th Annual General Meeting of the Company held on 07th August, 2023
Intimation for Presentation to analysts on financial Results for the quarter ended 30th June, 2023
Shareholding Pattern Q1
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation for Concall with Investors / Analyst Q1_2023-24
Intimation of the Board Meeting dated 07-08-2023
Newspaper advertisement in respect of Annual General Meeting and E-Voting Procedure
Newspaper advertisement regarding Intimation of the 50th AGM of the Company through VC/OAVM facility
Intimation for Trading Window Closure_Q1
USFDA Pre-Approval Inspection of Oral Oncology Manufacturing facility, Gujarat
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation under Regulation 30 of SEBI Listing Regulations_ Final NCLT Order wrt scheme of amalgamation of Curatio Health Care (I) Private Limited with Company
Intimation for Concall with Investors / Analyst Q4_2022-23
Intimation of the Board Meeting dated 30-05-2023
Redemption of Non-Convertible Debentures issued under ISIN:INE685A07108
Redemption of Non-Convertible Debentures issued under ISIN:INE685A07116

Details of Nodal Officer

Name : Chintan Trivedi

Designation : Company Secretary

E-mail Id : investorservices@torrentpharma.com

IEPF Authority - Refund web page

IEPF Authority - Refund web page >>